Fatty metamorphosis of the liver in patients with breast cancer: Possible associated factors

World Journal of Gastroenterology

Volumn 9, Issue 7, 2003, Pages 1618-1620

  Chu, Cheng Hsin ^a   Li, Shee Chan ^a   Shih, Shou Chuan ^a   Kao, Chin Roa ^a   Chou, Sun Yen ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRACEPTIVE AGENT; TAMOXIFEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; HEPATITIS; HEPATITIS C; HUMAN; HYPERLIPIDEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; PATHOGENESIS; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ULTRASOUND TRANSDUCER;

EID: 0041563669     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i7.1618     Document Type: Article

References (22)

1. Canada S. New Primary Sites of Malignant Neoplasms in Canada. Publication No 82-107, 1976
2. Lin TM, Chen KP, MacMahon B. Epidemiologic characteristics of cancer of the breast in Taiwan. Cancer 1971; 27:1 497-1504
3. Cheng CJ, You SL, Lin LH, Hsu WL, Yang YW. Cancer epidemiology and control in Taiwan: A brief review. Jpn J Clin Oncol 2002; 32: S66-81
4. Boring CC, Squires BA, Tong T. Cancer statistics, 1991. CA Cancer J Clin 1991; 41: 19-36
5. Lanza FL, Nelson RS. Fatty metamorphosis of the liver in malignant neoplasia. Special reference to carcinoma of the breast. Cancer 1968; 21: 699-705
6. Foster KJ, Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980; 53: 440-442
7. Saverymuttu SH, Joseph AEA, Maxell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986; 292: 13-15
8. Gary GE, Pike MC, Henderson BE. Breast cancer incidence and mortality rate in different countries in relation to known risk factors and dietary practices. Br J Cancer 1979; 39: 1-7
9. Choi NW, Howe GR, Miller AB. An epidemiologic study of breast cancer. Am J Epidemiol 1978; 107: 510-521
10. Hirayama T. Epidemiology of breast cancer with special reference to be role of diet. Prev Med 1978; 7: 173-195
11. Kirschner MA, Ertel N, Schneider G. Obesity, hormones, and cancer. Cancer Res 1981; 41: 3711-3717
12. Schapira DV, Kumar NB, Lyman GH, Cox CE. Abdominal obesity and breast cancer risk. Ann Intern Med 1990; 112: 182-186
13. Peyrat JP, Bonneterre R, Dijane J, Demaille A. IGF1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 1988; 48: 6429-6433
14. Kern WH, Hegar AH, Payne JH, DeWind LT. Fatty metamorphosis of the liver in morbid obesity. Arch Pathol 1973; 96: 342-346
15. Boyd NF, Campbell JE, Germanson T. Body weight and prognosis in breast cancer. J Natl Cancer Inst 1981; 67: 785-789
16. Senie RT, Rosen PP, Rhodes P. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med 1992; 51: 25-32
17. Ogawa Y, Murata Y, Nishioka A, Inomata T, Yoshida S. Tamoxifen-induced fatty liver in patients with breast cancer. Lancet 1998; 351: 725
18. Nguyen MC, Steward RB, Banerji MA. Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer. Int J Obesity 2001; 25: 296-298
19. Lombardi B. Consideration on the pathogenesis of fatty liver. Lab Invest 1966; 15: 1-20
20. Louis DB, Claude G, Cöme R. Severe lipemia induced by tamoxifen. Cancer 1986; 57: 2123-2126
21. Pino HC, Baptista A, Camilo ME, De Costa EB, Valente A, De Moura MC. Tamoxifen-associated steatohepatitis - Report of three cases. J Hepatol 1995; 23: 95-97
22. Cai Q, Bensen M, Greene R, Kirchner J. Tamoxifen-induced transient multifocal hepatic fatty infiltration. Am J Gastroenterol 2000; 95: 277-279